Get the Stockscreener App
4.48
0.22%
-0.010
After Hours:
4.47
-0.01
-0.22%
Cargo Therapeutics Inc stock is traded at $4.48, with a volume of 1.92M.
It is down -0.22% in the last 24 hours and up +8.47% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
See More
Previous Close:
$4.49
Open:
$4.485
24h Volume:
1.92M
Relative Volume:
1.43
Market Cap:
$206.57M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.2494
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
-2.82%
1M Performance:
+8.47%
6M Performance:
-67.63%
1Y Performance:
-74.40%
1-Day Range:
$4.47
$4.50
1-Week Range:
$4.40
$4.625
52-Week Range:
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.48 | 208.86M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
What drives CARGO Therapeutics Inc. stock priceOutstanding trading profits - Autocar Professional
CARGO Therapeutics Inc. Stock Analysis and ForecastMassive portfolio appreciation - Autocar Professional
Is CARGO Therapeutics Inc. a good long term investmentExplosive earning power - Autocar Professional
What analysts say about CARGO Therapeutics Inc. stockConsistently superior profits - jammulinksnews.com
How CARGO Therapeutics Inc. stock performs during market volatilityWatchlist Winner Update - Newser
What makes CARGO Therapeutics Inc. stock price move sharplyFree Predictions - Newser
Why CARGO Therapeutics Inc. stock attracts strong analyst attentionFree Growth Investment Group - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX, OLO, KLG, GNTY on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CARGO Therapeutics, Inc. (NasdaqCRGX), Olo Inc. (NYSEOLO), WK Kellogg Co (NYSEKLG), Guaranty Bancshares, Inc. (NYSEGNTY) - TradingView
Concentra adds CARGO Therapeutics to its biotech buy haul - The Pharma Letter
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives $15.00 Consensus PT from Brokerages - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - Defense World
Shareholder Alert: The Ademi Firm investigates whether CARGO Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders - The Malaysian Reserve
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CARGO Therapeutics, Inc. (NASDAQ: CRGX) - TradingView
Huge biotech investor buys 4 Bay Area companies on brink of collapse - SFGATE
Evaluating the Fairness of the Concentra Biosciences Acquisition of CARGO Therapeutics: Is There Undervalued Upside? - AInvest
CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc.CRGX - Business Wire
Concentra to acquire CARGO Therapeutics for $4.38 per share By Investing.com - Investing.com Nigeria
CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right - ADVFN
Concentra Picks Up Cargo In Latest Troubled Biotech Buyout - insights.citeline.com
Why CARGO Therapeutics Stock Is Gaining Today - Benzinga
New Analyst Forecast: $CRGX Given $5.0 Price Target - Quiver Quantitative
CRGX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Concentra Biosciences, LLC agreed to acquire CARGO Therapeutics, Inc. in a tender offer transaction. - MarketScreener
Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition - Investing.com Nigeria
Jefferies raises Cargo Therapeutics stock price target to $5 on Concentra acquisition By Investing.com - Investing.com South Africa
Latham Advises Cargo Therapeutics in Acquisition by Concentra Biosciences - Latham & Watkins LLP
Tang Capital makes bid for 4th Bay Area biotech in 3 months, offering to take out Cargo Therapeutics - The Business Journals
Cargo Therapeutics rises on Concentra Biosciences' buyout deal - TradingView
CARGO Therapeutics Announces Merger with Concentra Biosciences - TipRanks
Concentra Biosciences Acquires Cargo Therapeutics For $4.379 Per Share - Finimize
CARGO Therapeutics to be acquired by Concentra Biosciences in $4.379/share cash deal plus CVR; stock rises 8% - Seeking Alpha
Cargo Therapeutics Agrees to be Acquired by Concentra Biosciences - MarketScreener
Concentra to acquire CARGO Therapeutics for $4.38 per share - Investing.com
Cargo Therapeutics enters into agreement to be acquired by Concentra Biosciences - MarketScreener
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.91%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):